JOURNAL
Current Issue
Journal Archive
 

Chief Editor -
Abdulrazak Abyad MD, MPH, MBA, AGSF, AFCHSE

.........................................................

Publisher -
Lesley Pocock
medi+WORLD International
AUSTRALIA
Email
: lesleypocock@mediworld.com.au
publishermwi@gmail.com
.........................................................

Editorial Enquiries -
abyad@cyberia.net.lb
.........................................................

Advertising Enquiries -
lesleypocock@mediworld.com.au
.........................................................

While all efforts have been made to ensure the accuracy of the information in this journal, opinions expressed are those of the authors and do not necessarily reflect the views of The Publishers, Editor or the Editorial Board. The publishers, Editor and Editorial Board cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; or the views and opinions expressed. Publication of any advertisements does not constitute any endorsement by the Publishers and Editors of the product advertised.

The contents of this journal are copyright. Apart from any fair dealing for purposes of private study, research, criticism or review, as permitted under the Australian Copyright Act, no part of this program may be reproduced without the permission of the publisher.

WFM / MEJFM October Issue 7, 2025

Neurobiology of dementia

A Abyad

Correspondence
A. Abyad, MD, MPH, MBA, DBA, AGSF , AFCHSE
Consultant, Internal Medicine and Geriatric, Dar Al Shifa Hospital, Kuwait Chairman, Middle-East Academy for Medicine of Aging.
President, Middle East & North Africa Association on Aging & Alzheimer’s
Coordinator, Middle-East Primary Care Research Network
Coordinator, Middle-East Network on Aging
Email: aabyad@cyberia.net.lb

Received: August 2025. Accepted: September 2025; Published: October 2025.Citation: A. Abyad. Neurobiology of dementia.. World Family Medicine. October 2025; 23(7): 30 - 51
DOI: 10.5742/MEWFM.2025.805257903


Abstract


Dementia encompasses a group of progressive neurodegenerative disorders marked by cognitive, behavioural, and functional decline, underpinned by complex neurobiological processes. This chapter outlines the anatomical, cellular, and molecular mechanisms that drive disease onset and progression. Structural vulnerability of the hippocampus, cerebral cortex, white matter, and cognitive networks underlies characteristic clinical manifestations. At the microscopic level, neuro-inflammation, mitochondrial dysfunction, oxidative stress, excitotoxicity, impaired protein clearance, and synaptic loss converge to promote neuronal injury. Distinct proteinopathies—including amyloid- plaques and tau tangles in Alzheimer’s disease, -synuclein inclusions in Lewy body dementia, and TDP-43 or tau aggregates in frontotemporal lobar degeneration—
define specific dementia subtypes, yet share overlapping cascades of pathology. Vascular contributions, such as ischemia, hypoperfusion, and blood–brain barrier disruption, further compound neuronal vulnerability, highlighting the prevalence of mixed dementias. Collectively, these mechanisms illustrate dementia as a multifactorial disorder of network disintegration and cellular stress. Advancing insights into these processes are driving the development of biomarkers and disease-modifying therapies, paving the way for more precise, personalized approaches to diagnosis and care.





.................................................................................................................

I About MEJFM I Journal I Advertising I Author Info I Editorial Board I Resources I Contact us I Journal Archive I MEPRCN I Noticeboard I News and Updates
Disclaimer - ISSN 148-4196 - © Copyright 2007 medi+WORLD International Pty. Ltd. - All rights reserved